Home/Filings/4/0001209191-22-017968
4//SEC Filing

Girard Armand 4

Accession 0001209191-22-017968

CIK 0001253689other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 5:05 PM ET

Size

5.4 KB

Accession

0001209191-22-017968

Insider Transaction Report

Form 4
Period: 2022-03-09
Girard Armand
SVP, Strategy & Corporate Dev
Transactions
  • Sale

    Common Stock

    2022-03-09$1.09/sh2,339$2,55022,661 total
Footnotes (2)
  • [F1]The sales reported on this Form 4 were effected to satisfy tax withholding obligations in connection with the settlement of restricted stock units as part of a "sell to cover" transaction and do not represent discretionary trades by the reporting person.
  • [F2]The common stock was sold by the reporting person in a series of open market transactions on the transaction date with a volume weighted average sale price of $1.09. The range of sales prices for the transactions reported was $1.09 to $1.11 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

GLYCOMIMETICS INC

CIK 0001253689

Entity typeother

Related Parties

1
  • filerCIK 0001769636

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 5:05 PM ET
Size
5.4 KB